Hourly refreshTue, Oct 27, 2026

Press Release Database

Recent press releases, indexed by topic.
Topic

Biotech & pharma

2,264 press releases in English indexed under biotech & pharma.

Clear all filters
Keywords, dates and language
Sources
up to 10
Newswires (50)
Company newsrooms (91)
Companies
Releases linked to any of up to 10 companies
AllFinanceCryptoAISaaSHealthcareReal estateEnergyRetailAutomotiveGamingMediaEducation
+ 33 more topics
DownloadExcelTXT
Finance · Healthcare

Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil® Development Amid Growing Federal Support for Botanical Drug Pathways

Endovia financing comes as FDA and Congress increase focus on advancing and incentivizing regulated development of botanical and plant-derived medicines

Sep 22 · 13:30GlobeNewswire
Finance · Food & drink

Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Beta Bionics, Inc. (NASDAQ: BBNX); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: SMPL): Grabar Law Office is Investigating Claims on Your Behalf

Aardvark Therapeutics (NASDAQ: AARD); Beta Bionics (NASDAQ: BBNX); PROCEPT BioRobotics Corp. (NASDAQ: PRCT); and The Simply Good Foods Co. (NASDAQ: SMPL)

Sep 22 · 12:14GlobeNewswire
AI · SaaS

AIQ by Fullspan Health Gives Pharma Marketers a Way to Measure and Improve Visibility in AI Search

AIQ analysis finds Fullspan Health's content appearing in up to 81% of AI citations for key condition questions, and as much as 3.6x more often than competitors across ChatGPT, Claude and Gemini NEW YORK, Sept. 22, 2026 -- Fullspan Health™, a unified B2B healthcare platform...

Sep 22 · 12:10PR Newswire
Biotech & pharma

Iterion Therapeutics Announces Promising Phase 1b Data for Tegavivint in Combination with Osimertinib in First-Line EGFR-Mutated Non-Small Cell Lung Cancer

Combination demonstrating 79% objective response rate (ORR), including complete responses (CRs) in 16% of patients (compared to 1% historically for osimertinib alone) Median progression-free survival (mPFS) of 19.9 months and median overall survival (mOS) of 48.8 months observed in the...

Sep 22 · 12:09PR Newswire
Healthcare · Energy

Cold Chain Expansion Fuels Mexico Refrigerated Transport Market, Set to Reach US$545.25 Million by 2034 at 4.22% CAGR

Cold-chain demand is rising across food, pharma and cross-border trade, creating opportunities in smart monitoring, multi-temperature fleets and energy-efficient refrigeration Cold-chain demand is rising across food, pharma and cross-border trade, creating opportunities in smart monitoring, multi-temperature fleets and energy-efficient refrigeration

Sep 22 · 12:05GlobeNewswire
Biotech & pharma

SCYNEXIS Appoints Seasoned Industry Veteran Steven K. Burke, M.D., to its Board of Directors

New director brings nephrology development expertise and over 30 years of experience in the biopharmaceutical industry New director brings nephrology development expertise and over 30 years of experience in the biopharmaceutical industry

Sep 22 · 12:00GlobeNewswire
Healthcare · Biotech & pharma

PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncology

39.3 months median overall survival in first-line (1L) R/M immune checkpoint inhibitor naïve patients

Sep 22 · 12:00GlobeNewswire
Healthcare · Biotech & pharma

Cleanroom Lighting Market 2026: Pharma, Biotech and Semiconductor Expansion Fuels New Growth Opportunities

LED upgrades, smart IoT controls and recessed fixtures offer opportunities as pharma, biotech and chipmaking expand cleanrooms, led by Asia-Pacific and stricter compliance. LED upgrades, smart IoT controls and recessed fixtures offer opportunities as pharma, biotech and chipmaking expand cleanrooms, led by Asia-Pacific and stricter compliance.

Sep 22 · 08:50GlobeNewswire
SaaS · Biotech & pharma

Applied Biopharm Consulting Develops Predictive Tool to Support Antibody Formulation Development

CORK, IRELAND. September 22nd, 2026 – Applied Biopharm Consulting Ltd has developed Applied BioSight, a predictive computational platform for monoclonal antibody formulation development that integrates amino acid sequence analysis, physicochemical modelling and a reference database containing sequence and formulation information for 144 approved commercial antibodies. By combining sequence-derived molecular properties with established commercial formulation evidence, […]

Sep 22 · 08:03PR Fire
Industrial · Biotech & pharma

ExploRNA Therapeutics and Łukasiewicz - IChP Announce Strategic Partnership to Advance GMP Manufacturing of Next-Generation mRNA Cap Analogs

WARSAW, Poland, Sept. 22, 2026 -- ExploRNA Therapeutics, a pioneering biotechnology company specializing in novel mRNA capping technologies, and the Łukasiewicz Research Network – Industrial Chemistry Institute (Łukasiewicz - IChP) today announced a strategic partnership. The...

Sep 22 · 06:15PR Newswire
Healthcare · Biotech & pharma

Opterion Health Announces Positive Phase 1 Results for OPT101, Supporting Advancement to Phase 2a

Opterion Health reports positive Phase 1 OPT101 results, supporting Phase 2a and advancing a differentiated non-glucose approach to peritoneal dialysis.

Sep 22 · 06:15GlobeNewswire
Healthcare · Education

China Medical University Hospital Named to Newsweek's World's Best Specialized Hospitals 2027 for Neurosurgery

CMUH is the only hospital in Taiwan recognized in the Neurosurgery category, reflecting its strengths in complex neurosurgery, integrated neurological care and cell therapy TAICHUNG, Sept. 22, 2026 -- China Medical University Hospital (CMUH) has been named to Newsweek's...

Sep 22 · 06:01PR Newswire